Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma

• Váldodahkkit: Fenglin Li (Dahkki), Yi Lai (Dahkki), Jiayi Ye (Dahkki), Madiha Saeed (Dahkki), Yijing Dang (Dahkki), Zhifeng Zou (Dahkki), Fangmin Chen (Dahkki), Wen Zhang (Dahkki), Zhiai Xu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2022-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Glioblastoma (GBM) therapy is severely impaired by the blood-brain barrier (BBB) and invasive tumor growth in the central nervous system. To improve GBM therapy, we herein presented a dual-targeting nanotheranostic for second near-infrared (NIR-II) fluorescence imaging-guided photo-immunotherapy. Fi...